showed a trendp = 0.06
Survival curve analysis showed a trend to a reduced VAP risk associated with AG 100 use ( p = 0.06) ( Table 2 , Fig 4 , see S1 File for further details).
Survival curve analysis showed a trend to a reduced VAP risk associated with AG 100 use ( p = 0.06) ( Table 2 , Fig 4 , see S1 File for further details).
A clear trend to a lower incidence of VAP episodes was observed in patients randomized to AG group.